|
Session 42
Poster Discussion
Poster Discussion: Maternal ART and Feeding Practices: Impact on Infant Outcomes
Wednesday, 2-3 pm
Room: Room 302-304 |
636
 |
18-Month HIV-free Survival by Infant Feeding Practices in Children of HIV-infected Women in South Africa: The Vertical Transmission Study
Nigel Rollins*1, R Becquet2,3,4, R Bland2,5, A Coutsoudis1, H Coovadia6, and M L Newell2,7
1Univ of KwaZulu Natal, Durban, South Africa; 2Africa Ctr for Hlth and Population Studies, Univ of KwaZulu Natal, Somkhele, South Africa; 3INSERM U593, Bordeaux, France; 4Inst for Publ Hlth, Epi and Devt, Univ Victor Segalen, Bordeaux, France; 5Univ of Glasgow, UK; 6Ctr for HIV/AIDS Networking, Univ of KwaZulu Natal, Durban, South Africa; and 7Ctr for Paediatric Epi and Biostatistics, Inst of Child Hlth, Univ Coll London, UK |
637
|
Risk Factors for Mother-to-Child Transmission of HIV-1 from Breastfeeding in a Randomized Clinical Trial in Botswana: The Mashi Study
Roger Shapiro*1, L Smeaton2, S Lockman3, I Thior4, R Rossenkhan4, C Wester4, L Stevens4, J Leidner2, J Makhema4, and M Essex5
1Beth Israel Deaconess Med Ctr, Boston, MA, US; 2Harvard Sch of Publ Hlth, Ctr for Biostatistics in AIDS Res, Boston, MA, US; 3Brigham and Women`s Hosp, Boston, MA, US; 4Botswana Harvard Sch of Publ Hlth AIDS Initiative Partnership for HIV Res and Ed, Gaborone; and 5Harvard Sch of Publ Hlth, Boston, MA, US |
638
|
HIV-free Survival at 12 Months among Children Born to HIV-infected Women Receiving Antiretrovirals from 34 to 36 Weeks of Pregnancy
Isabelle de Vincenzi and The Kesho Bora Study Group
WHO, Geneva, Switzerland |
639
|
Decrease in HIV-1 Mother-to-Child Transmission in Women Receiving Postnatal HAART: 12-Month Follow-up Data
M Marazzi1, L Palombi2, G Liotta2, P Germano3, N Abdul Majid4, I Zimba4, A Doro Altan2, G Bortolot3, and Karin Nielsen-Saines*5
1LUMSA Univ, Rome, Italy; 2Univ of Tor Vergata, Rome, Italy; 3DREAM Prgm, Community of St Egidio, Italy; 4Benfica Hlth Ctr, Maputo, Mozambique; and 5David Geffen Sch of Med, Univ of California, Los Angeles, US |
640
|
Comparison of Adverse Fetal Outcomes in HIV-1-infected Antiretroviral-naïve Pregnant Women Who Have Received Combivir and Either Nevirapine or Nelfinavir for Prevention of Mother-to-Child Transmission Antenatally
Rose Masaba*1, R Ndivo1, I Nyangau1, K Achola1, C Zeh2, M Thigpen3, P Weidle3, and T Thomas2
1Kenya Med Res Inst, Kisumu; 2CDC Kenya, Kisumu; and 3CDC, Atlanta, GA, US |
641
|
Low Birth Weight with Nevirapine-based ART in Abidjan, Côte d’Ivoire: The ANRS Ditrame Plus Cohort and MTCT-Plus Initiative, 2001 to 2007
Didier Koumavi Ekouevi*1,2, B Tonwe-Gold1,3, R Becquet1, P Coffie1,2, P Toure3, V Leroy1, I Viho2, S Blanche4, F Dabis1, and E Abrams5
1INSERM U593, Inst for Publ Hlth, Epi and Devt, Bordeaux, France; 2Natl Agency for AIDS Res Ditrame Plus Project, Abidjan, Côte d`Ivoire; 3ACONDA, NGO, Abidjan, Côte d`Ivoire; 4Hosp Necker, Paris France; and 5MTCT-Plus Initiative, New York, NY, US |
|
